Ferritin Quantitative Test

HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)

HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.

Product Detail

Application

HbA1c is a product of the non-enzymatic chemical reaction between glucose and the N-terminus of the hemoglobin protein's β-chain (valine) amino groups. From a molecular biology perspective, HbA1c belongs to a diverse group of molecules termed advanced glycation end-products (AGEs).

 

In both diabetic and non-diabetic individuals, the relative levels of HbA1c reflect the duration and severity of hyperglycemic episodes, as well as the overall exposure to extracellular glucose present in the circulation. HbA1c levels, at varying cut-offs, have been developed as biomarkers for both the diagnosis of diabetes and the assessment of chronic glycemic control.

 

HbA1c reflects the average plasma glucose concentration over the previous 8 to 12 weeks. It can be measured at any time of the day and does not require special preparation, such as fasting. These properties have made HbA1c the preferred test for assessing glycemic control in people with diabetes.

 

More recently, there has been substantial interest in using HbA1c as a diagnostic test for diabetes and as a screening test for individuals at high risk of developing the condition. The use of HbA1c can avoid the problem of day-to-day variability in glucose values and eliminates the need for fasting and preceding dietary preparations. These advantages have important implications for the early identification and treatment of diabetes, which have been strongly advocated in recent years.

 

A persistently elevated level of HbA1c increases the risk of various vascular complications, such as coronary disease, heart attack, stroke, heart failure, kidney failure, blindness, erectile dysfunction, neuropathy, gangrene, gastroparesis, and short-term complications of surgery, including poor wound healing.

 

Product Specification

Sample Volume

WB: 10μL

Test Time

15 mins

Measuring Range

4.2-20%

Pack

20T40T100T

Storage

2~30

 

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

 

Clinical significance

Diagnosis and Monitoring of Diabetes

Assessment of Long-Term Blood Glucose Control

Cardiovascular Risk Assessment

Medication Adjustment and Treatment Planning

Screening for Prediabetes

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)
C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)
C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Insulin (INS) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.
Biotime PROG Rapid Quantitative Test
PROG Rapid Quantitative Test
Progesterone(PROG) is produced by the corpus luteum or in females, the male progesterone level is very low and mainly produced by adrenal cortex. Biotime PROG test is used for determining ovulation, monitoring progesterone therapy and evaluating early pregnancy status.
hs cTnI Rapid Quantitative Test
hs cTnI Rapid Quantitative Test
cTnI, a crucial cardiac biomarker, assists in detecting and managing acute myocardial infarction and assessing patient risk in cardiovascular events. Biotime's hs-cTnI offers high sensitivity, compatibility with versatile samples, and stable performance. Trust our ideal biomarker for comprehensive acute coronary syndrome evaluation.
FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)
FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)
FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Free thyroxine 4 (FT4) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.
Biotime cTnI rapid quantitative test
cTnI Rapid Quantitative Test
cTnI is a myocardial marker with high specificity and good sensitivity. The Biotime cTnI test kit has a wide detection range and high accuracy.
Biotime IL-6 Rapid Quantitative Test
IL-6 Rapid Quantitative Test
Interleukin 6 (IL-6) is an interleukin that acts as both a pro inflammatory cytokine and an anti-inflammatory myokine. osteoblasts secrete IL-6 to stimulate osteoclast formation. Smooth muscle cells in the tunica media of many blood vessels also produce IL-6 as a pro-inflammatory cytokine.
biotime tPSA Rapid Quantitative Test
tPSA Rapid Quantitative Test
Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact